{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:14:50Z","timestamp":1776759290443,"version":"3.51.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/143717\/2019"],"award-info":[{"award-number":["SFRH\/BD\/143717\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011776","name":"Instituto Portugu\u00eas de Oncologia do Porto","doi-asserted-by":"publisher","award":["CI-IPOP-27"],"award-info":[{"award-number":["CI-IPOP-27"]}],"id":[{"id":"10.13039\/501100011776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Screening plays a key role in secondary prevention of cervical cancer. High-risk human papillomavirus (hrHPV) testing, a highly sensitive test but with limited specificity, has become the gold standard frontline for screening programs. Thus, the importance of effective triage strategies, including DNA methylation markers, has been emphasized. Despite the potential reported in individual studies, methylation markers still require validation before being recommended for clinical practice. This systematic review and meta-analysis aimed to evaluate the performance of DNA methylation-based biomarkers for detecting high-grade intraepithelial lesions (HSIL) in hrHPV-positive women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Hence, PubMed, Scopus, and Cochrane databases were searched for studies that assessed methylation in hrHPV-positive women in cervical scrapes. Histologically confirmed HSIL was used as endpoint and QUADAS-2 tool enabled assessment of study quality. A bivariate random-effect model was employed to pool the estimated sensitivity and specificity as well as positive (PPV) and negative (NPV) predictive values.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-three studies were included in this meta-analysis, from which cohort and referral population-based studies corresponded to nearly 65%. Most of the women analyzed were Dutch, and <jats:italic>CADM1, FAM19A4, MAL,<\/jats:italic> and <jats:italic>miR124-2<\/jats:italic> were the most studied genes. Pooled sensitivity and specificity were 0.68 (CI 95% 0.63\u20130.72) and 0.75 (CI 95% 0.71\u20130.80) for cervical intraepithelial neoplasia (CIN) 2+\u2009detection, respectively. For CIN3+\u2009detection, pooled sensitivity and specificity were 0.78 (CI 95% 0.74\u20130.82) and 0.74 (CI 95% 0.69\u20130.78), respectively. For pooled prevalence, PPV for CIN2+\u2009and CIN3+\u2009detection were 0.514 and 0.392, respectively. Furthermore, NPV for CIN2+\u2009and CIN3+\u2009detection were 0.857 and 0.938, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This meta-analysis confirmed the great potential of DNA methylation-based biomarkers as triage tool for hrHPV-positive women in cervical cancer screening. Standardization and improved validation are, however, required. Nevertheless, these markers might represent an excellent alternative to cytology and genotyping for colposcopy referral of hrHPV-positive women, allowing for more cost-effective screening programs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-023-01537-2","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T17:01:53Z","timestamp":1690995713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Sofia","family":"Salta","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o","family":"Lobo","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Magalh\u00e3es","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"issue":"3","key":"1537_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1537_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3322\/caac.21139","volume":"62","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147\u201372.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1537_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41416-020-0920-9","volume":"123","author":"M Kyrgiou","year":"2020","unstructured":"Kyrgiou M, Arbyn M, Bergeron C, Bosch FX, Dillner J, Jit M, et al. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). Br J Cancer. 2020;123(4):510\u20137.","journal-title":"Br J Cancer"},{"issue":"10167","key":"1537_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169\u201382.","journal-title":"Lancet"},{"issue":"9916","key":"1537_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524\u201332.","journal-title":"Lancet"},{"issue":"2","key":"1537_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","volume":"136","author":"TC Wright","year":"2015","unstructured":"Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015;136(2):189\u201397.","journal-title":"Gynecol Oncol"},{"key":"1537_CR7","unstructured":"European Cancer Organisation. Viral protection: achieving the possible. A four step plan for eliminating HPV cancers in Europe. 2020."},{"issue":"3","key":"1537_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ygyno.2020.12.038","volume":"160","author":"S Kaljouw","year":"2021","unstructured":"Kaljouw S, Jansen EEL, Aitken CA, Harrijvan LM, Naber SK, de Kok I. Reducing unnecessary referrals for colposcopy in hrHPV-positive women within the Dutch cervical cancer screening programme: a modelling study. Gynecol Oncol. 2021;160(3):713\u201320.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1537_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ygyno.2016.10.031","volume":"144","author":"TC Wright Jr","year":"2017","unstructured":"Wright TC Jr, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, et al. Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trial. Gynecol Oncol. 2017;144(1):51\u20136.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"1537_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000450595","volume":"60","author":"AT Lorincz","year":"2016","unstructured":"Lorincz AT. Virtues and weaknesses of DNA methylation as a test for cervical cancer prevention. Acta Cytol. 2016;60(6):501\u201312.","journal-title":"Acta Cytol"},{"issue":"8","key":"1537_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/14789450.2021.1980387","volume":"18","author":"C Guzel","year":"2021","unstructured":"Guzel C, van Sten-Van\u2019t HJ, de Kok I, Govorukhina NI, Boychenko A, Luider TM, et al. Molecular markers for cervical cancer screening. Expert Rev Proteomics. 2021;18(8):675\u201391.","journal-title":"Expert Rev Proteomics"},{"issue":"8","key":"1537_CR12","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-10-2548","volume":"17","author":"AT Hesselink","year":"2011","unstructured":"Hesselink AT, Heideman DA, Steenbergen RD, Coupe VM, Overmeer RM, Rijkaart D, et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin Cancer Res Off J Am Assoc Cancer Res. 2011;17(8):2459\u201365.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"2","key":"1537_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ijc.33320","volume":"148","author":"J Bonde","year":"2021","unstructured":"Bonde J, Floore A, Ejegod D, Vink FJ, Hesselink A, van de Ven PM, et al. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: a large European multicenter study. J Int Cancer. 2021;148(2):396\u2013405.","journal-title":"J Int Cancer"},{"issue":"2","key":"1537_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ygyno.2016.02.012","volume":"141","author":"LMA De Strooper","year":"2016","unstructured":"De Strooper LMA, Verhoef VMJ, Berkhof J, Hesselink AT, de Bruin HME, van Kemenade FJ, et al. Validation of the FAM19A4\/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women. Gynecol Oncol. 2016;141(2):341\u20137.","journal-title":"Gynecol Oncol"},{"issue":"14","key":"1537_CR15","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1158\/1078-0432.CCR-17-3615","volume":"24","author":"W Verlaat","year":"2018","unstructured":"Verlaat W, Snoek BC, Heideman DAM, Wilting SM, Snijders PJF, Novianti PW, et al. Identification and validation of a 3-gene methylation classifier for HPV-based cervical screening on self-samples. Clin Cancer Res Off J Am Assoc Cancer Res. 2018;24(14):3456\u201364.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"6","key":"1537_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/bjc.2014.392","volume":"111","author":"A Boers","year":"2014","unstructured":"Boers A, Bosgraaf RP, van Leeuwen RW, Schuuring E, Heideman DA, Massuger LF, et al. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women. Br J Cancer. 2014;111(6):1095\u2013101.","journal-title":"Br J Cancer"},{"issue":"12","key":"1537_CR17","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1158\/1940-6207.CAPR-14-0237","volume":"7","author":"LM De Strooper","year":"2014","unstructured":"De Strooper LM, Meijer CJ, Berkhof J, Hesselink AT, Snijders PJ, Steenbergen RD, et al. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2\/3 lesions. Cancer Prev Res. 2014;7(12):1251\u20137.","journal-title":"Cancer Prev Res"},{"issue":"4","key":"1537_CR18","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/ijc.29824","volume":"138","author":"R Luttmer","year":"2016","unstructured":"Luttmer R, De Strooper LM, Berkhof J, Snijders PJ, Dijkstra MG, Uijterwaal MH, et al. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16\/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study). J Int Cancer. 2016;138(4):992\u20131002.","journal-title":"J Int Cancer"},{"issue":"5","key":"1537_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/bjc.2016.200","volume":"115","author":"R Luttmer","year":"2016","unstructured":"Luttmer R, De Strooper LM, Dijkstra MG, Berkhof J, Snijders PJ, Steenbergen RD, et al. FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women. Br J Cancer. 2016;115(5):579\u201387.","journal-title":"Br J Cancer"},{"issue":"1","key":"1537_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ygyno.2015.01.550","volume":"137","author":"VM Verhoef","year":"2015","unstructured":"Verhoef VM, van Kemenade FJ, Rozendaal L, Heideman DA, Bosgraaf RP, Hesselink AT, et al. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1\/MAL methylation analysis on cervical scrapes. Gynecol Oncol. 2015;137(1):55\u20139.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1537_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","volume":"15","author":"VM Verhoef","year":"2014","unstructured":"Verhoef VM, Bosgraaf RP, van Kemenade FJ, Rozendaal L, Heideman DA, Hesselink AT, et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. Lancet Oncol. 2014;15(3):315\u201322.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1537_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ygyno.2014.08.003","volume":"135","author":"VM Verhoef","year":"2014","unstructured":"Verhoef VM, Heideman DA, van Kemenade FJ, Rozendaal L, Bosgraaf RP, Hesselink AT, et al. Methylation marker analysis and HPV16\/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer. Gynecol Oncol. 2014;135(1):58\u201363.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1537_CR23","doi-asserted-by":"publisher","first-page":"125 e1","DOI":"10.1016\/j.cmi.2020.03.018","volume":"27","author":"FJ Vink","year":"2021","unstructured":"Vink FJ, Lissenberg-Witte BI, Meijer C, Berkhof J, van Kemenade FJ, Siebers AG, et al. FAM19A4\/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort. Clin Microbiol Infect. 2021;27(1):125 e1-e6.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1537_CR24","doi-asserted-by":"publisher","first-page":"e91905","DOI":"10.1371\/journal.pone.0091905","volume":"9","author":"A Hansel","year":"2014","unstructured":"Hansel A, Steinbach D, Greinke C, Schmitz M, Eiselt J, Scheungraber C, et al. A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women. PLoS One. 2014;9(3):e91905.","journal-title":"PLoS One"},{"issue":"11","key":"1537_CR25","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1002\/ijc.30008","volume":"138","author":"AT Lorincz","year":"2016","unstructured":"Lorincz AT, Brentnall AR, Scibior-Bentkowska D, Reuter C, Banwait R, Cadman L, et al. Validation of a DNA methylation HPV triage classifier in a screening sample. J Int Cancer. 2016;138(11):2745\u201351.","journal-title":"J Int Cancer"},{"key":"1537_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13148-017-0419-2","volume":"9","author":"M Schmitz","year":"2017","unstructured":"Schmitz M, Wunsch K, Hoyer H, Scheungraber C, Runnebaum IB, Hansel A, et al. Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women. Clin Epigenet. 2017;9:118.","journal-title":"Clin Epigenet"},{"issue":"4","key":"1537_CR27","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/ijc.31897","volume":"144","author":"RW van Leeuwen","year":"2019","unstructured":"van Leeuwen RW, Ostrbenk A, Poljak M, van der Zee AGJ, Schuuring E, Wisman GBA. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort. J Int Cancer. 2019;144(4):746\u201354.","journal-title":"J Int Cancer"},{"issue":"1","key":"1537_CR28","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1186\/s12885-018-4877-5","volume":"18","author":"Q Bu","year":"2018","unstructured":"Bu Q, Wang S, Ma J, Zhou X, Hu G, Deng H, et al. The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women. BMC Cancer. 2018;18(1):1182.","journal-title":"BMC Cancer"},{"issue":"7","key":"1537_CR29","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/ijc.33430","volume":"148","author":"N Li","year":"2021","unstructured":"Li N, Hu Y, Zhang X, Liu Y, He Y, van der Zee AGJ, et al. DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population. Int J Cancer. 2021;148(7):1768\u201377.","journal-title":"Int J Cancer"},{"issue":"37","key":"1537_CR30","doi-asserted-by":"publisher","first-page":"62274","DOI":"10.18632\/oncotarget.19459","volume":"8","author":"Y Tian","year":"2017","unstructured":"Tian Y, Yuan Wu NY, Liou YL, Yeh CT, Cao L, Kang YN, et al. Utility of gene methylation analysis, cytological examination, and HPV-16\/18 genotyping in triage of high-risk human papilloma virus-positive women. Oncotarget. 2017;8(37):62274\u201385.","journal-title":"Oncotarget"},{"issue":"42","key":"1537_CR31","doi-asserted-by":"publisher","first-page":"44373","DOI":"10.18632\/oncotarget.6250","volume":"6","author":"A Yin","year":"2015","unstructured":"Yin A, Zhang Q, Kong X, Jia L, Yang Z, Meng L, et al. JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix. Oncotarget. 2015;6(42):44373\u201387.","journal-title":"Oncotarget"},{"issue":"7","key":"1537_CR32","first-page":"10577","volume":"10","author":"L Yuan","year":"2017","unstructured":"Yuan L, Hu Y, Zhou Z, Gong Y, Wang R, Li N. Quantitative methylation analysis to detect cervical (Pre)-cancerous lesions in high-risk HPV-positive women. Int J Clin Exp Med. 2017;10(7):10577\u201386.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"1537_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/QAI.0000000000000744","volume":"70","author":"H De Vuyst","year":"2015","unstructured":"De Vuyst H, Franceschi S, Plummer M, Mugo NR, Sakr SR, Meijer CJ, et al. Methylation levels of CADM1, MAL, and MIR124-2 in cervical scrapes for triage of HIV-infected, high-risk HPV-positive women in Kenya. J Acquir Immune Defic Syndr. 2015;70(3):311\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"1537_CR34","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1002\/ijc.31976","volume":"144","author":"DA Cook","year":"2019","unstructured":"Cook DA, Krajden M, Brentnall AR, Gondara L, Chan T, Law JH, et al. Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial. Int J Cancer. 2019;144(10):2587\u201395.","journal-title":"Int J Cancer"},{"key":"1537_CR35","doi-asserted-by":"publisher","first-page":"100280","DOI":"10.1016\/j.jcpo.2021.100280","volume":"28","author":"P Baker","year":"2021","unstructured":"Baker P, Kelly D, Medeiros R, Morrissey M, Price R. Eliminating HPV-caused cancers in Europe: achieving the possible. J Cancer Policy. 2021;28:100280.","journal-title":"J Cancer Policy"},{"key":"1537_CR36","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020."},{"issue":"11","key":"1537_CR37","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1002\/ijc.33778","volume":"149","author":"S Salta","year":"2021","unstructured":"Salta S, Maia-Moco L, Estevao-Pereira H, Sequeira JP, Vieira R, Bartosch C, et al. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: a feasibility study. Int J Cancer. 2021;149(11):1916\u201325.","journal-title":"Int J Cancer"},{"issue":"2","key":"1537_CR38","doi-asserted-by":"publisher","first-page":"200 e1","DOI":"10.1016\/j.ajog.2020.08.026","volume":"224","author":"DL Loopik","year":"2021","unstructured":"Loopik DL, Koenjer LM, Siebers AG, Melchers WJG, Bekkers RLM. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program. Am J Obstet Gynecol. 2021;224(2):200 e1-e9.","journal-title":"Am J Obstet Gynecol"},{"key":"1537_CR39","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2021."},{"issue":"1","key":"1537_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/M17-1609","volume":"168","author":"PE Castle","year":"2018","unstructured":"Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, et al. Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical cancer: an observational cohort study. Ann Intern Med. 2018;168(1):20\u20139.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1537_CR41","doi-asserted-by":"publisher","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","volume":"106","author":"JC Gage","year":"2014","unstructured":"Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, et al. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. J Natl Cancer Inst. 2014;106(8):dju153.","journal-title":"J Natl Cancer Inst"},{"key":"1537_CR42","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: web annex A: syntheses of evidence. 2021."},{"issue":"12","key":"1537_CR43","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/cncy.21596","volume":"123","author":"LA Richardson","year":"2015","unstructured":"Richardson LA, El-Zein M, Ramanakumar AV, Ratnam S, Sangwa-Lugoma G, Longatto-Filho A, et al. HPV DNA testing with cytology triage in cervical cancer screening: influence of revealing HPV infection status. Cancer Cytopathol. 2015;123(12):745\u201354.","journal-title":"Cancer Cytopathol"},{"key":"1537_CR44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02433","author":"WW Kremer","year":"2022","unstructured":"Kremer WW, Dick S, Heideman DAM, Steenbergen RDM, Bleeker MCG, Verhoeve HR, et al. Clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4\/miR124-2 DNA methylation (CONCERVE Study). J Clin Oncol Off J Am Soc Clin Oncol. 2022. https:\/\/doi.org\/10.1200\/JCO.21.02433.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"1537_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41416-021-01614-4","volume":"126","author":"S Dick","year":"2022","unstructured":"Dick S, Vink FJ, Heideman DAM, Lissenberg-Witte BI, Meijer C, Berkhof J. Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4\/miR124-2 methylation and HPV genotyping. Br J Cancer. 2022;126(2):259\u201364.","journal-title":"Br J Cancer"},{"issue":"11","key":"1537_CR46","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41416-019-0593-4","volume":"121","author":"H Kelly","year":"2019","unstructured":"Kelly H, Benavente Y, Pavon MA, De Sanjose S, Mayaud P, Lorincz AT. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis. Br J Cancer. 2019;121(11):954\u201365.","journal-title":"Br J Cancer"},{"issue":"10","key":"1537_CR47","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982\u201390.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"1537_CR48","first-page":"211","volume":"9","author":"RM Harbord","year":"2009","unstructured":"Harbord RM, Whiting P. Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stand Genomic Sci. 2009;9(2):211\u201329.","journal-title":"Stand Genomic Sci"},{"key":"1537_CR49","unstructured":"Dwamena B, Sylvester R, Carlos R. Midas: meta-analysis of diagnostic accuracy studies. Accessed on February 8, 2017. Available at: http:\/\/fmwww.bc.edu\/repec\/bocode\/m\/midas.pdf View in Article. 2009."},{"issue":"5","key":"1537_CR50","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/sim.2992","volume":"27","author":"AH Zwinderman","year":"2008","unstructured":"Zwinderman AH, Bossuyt PM. We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med. 2008;27(5):687\u201397.","journal-title":"Stat Med"},{"key":"1537_CR51","unstructured":"Doebler P. Meta-analysis of diagnostic accuracy (Version 0.5.11) [Software] 2022 Available from: cran.r-project.org\/web\/packages\/mada\/mada.pdf."},{"key":"1537_CR52","first-page":"15","volume":"1","author":"P Doebler","year":"2015","unstructured":"Doebler P, Holling H. Meta-analysis of diagnostic accuracy with mada. R Packag. 2015;1:15.","journal-title":"R Packag"},{"issue":"1","key":"1537_CR53","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jaci.2020.04.058","volume":"147","author":"B Sousa-Pinto","year":"2021","unstructured":"Sousa-Pinto B, Tarrio I, Blumenthal KG, Araujo L, Azevedo LF, Delgado L, et al. Accuracy of penicillin allergy diagnostic tests: a systematic review and meta-analysis. J Allergy Clin Immunol. 2021;147(1):296\u2013308.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1537_CR54","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"key":"1537_CR55","doi-asserted-by":"publisher","first-page":"m2632","DOI":"10.1136\/bmj.m2632","volume":"370","author":"JP Salameh","year":"2020","unstructured":"Salameh JP, Bossuyt PM, McGrath TA, Thombs BD, Hyde CJ, Macaskill P, et al. Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist. BMJ. 2020;370:m2632.","journal-title":"BMJ"},{"issue":"4","key":"1537_CR56","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, the P-DTAG, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388\u201396.","journal-title":"JAMA"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-023-01537-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-023-01537-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-023-01537-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T18:02:13Z","timestamp":1690999333000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-023-01537-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1537"],"URL":"https:\/\/doi.org\/10.1186\/s13148-023-01537-2","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}